Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Activity of Estafietin and Analogues on Trypanosoma cruzi and Leishmania braziliensis.

Sülsen VP, Lizarraga EF, Elso OG, Cerny N, Sanchez Alberti A, Bivona AE, Malchiodi EL, Cazorla SI, Catalán CAN.

Molecules. 2019 Mar 28;24(7). pii: E1209. doi: 10.3390/molecules24071209.

2.

Preparation of Sesquiterpene Lactone Derivatives: Cytotoxic Activity and Selectivity of Action.

Beer MF, Bivona AE, Sánchez Alberti A, Cerny N, Reta GF, Martín VS, Padrón JM, Malchiodi EL, Sülsen VP, Donadel OJ.

Molecules. 2019 Mar 20;24(6). pii: E1113. doi: 10.3390/molecules24061113.

3.

Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine.

Bivona AE, Sánchez Alberti A, Matos MN, Cerny N, Cardoso AC, Morales C, González G, Cazorla SI, Malchiodi EL.

PLoS Negl Trop Dis. 2018 Mar 30;12(3):e0006384. doi: 10.1371/journal.pntd.0006384. eCollection 2018 Mar.

4.

Engineered trivalent immunogen adjuvanted with a STING agonist confers protection against Trypanosoma cruzi infection.

Sanchez Alberti A, Bivona AE, Cerny N, Schulze K, Weißmann S, Ebensen T, Morales C, Padilla AM, Cazorla SI, Tarleton RL, Guzmán CA, Malchiodi EL.

NPJ Vaccines. 2017 Apr 10;2:9. doi: 10.1038/s41541-017-0010-z. eCollection 2017.

5.

Assessment of sesquiterpene lactones isolated from Mikania plants species for their potential efficacy against Trypanosoma cruzi and Leishmania sp.

Laurella LC, Cerny N, Bivona AE, Sánchez Alberti A, Giberti G, Malchiodi EL, Martino VS, Catalan CA, Alonso MR, Cazorla SI, Sülsen VP.

PLoS Negl Trop Dis. 2017 Sep 25;11(9):e0005929. doi: 10.1371/journal.pntd.0005929. eCollection 2017 Sep.

6.

A prime-boost immunization with Tc52 N-terminal domain DNA and the recombinant protein expressed in Pichia pastoris protects against Trypanosoma cruzi infection.

Matos MN, Sánchez Alberti A, Morales C, Cazorla SI, Malchiodi EL.

Vaccine. 2016 Jun 14;34(28):3243-51. doi: 10.1016/j.vaccine.2016.05.011. Epub 2016 May 10.

PMID:
27177947
7.

Attenuated Salmonella sp. as a DNA Delivery System for Trypanosoma cruzi Antigens.

Bivona AE, Cerny N, Alberti AS, Cazorla SI, Malchiodi EL.

Methods Mol Biol. 2016;1404:683-95. doi: 10.1007/978-1-4939-3389-1_44.

PMID:
27076330
8.

Coadministration of cruzipain and GM-CSF DNAs, a new immunotherapeutic vaccine against Trypanosoma cruzi infection.

Cerny N, Sánchez Alberti A, Bivona AE, De Marzi MC, Frank FM, Cazorla SI, Malchiodi EL.

Hum Vaccin Immunother. 2016;12(2):438-50. doi: 10.1080/21645515.2015.1078044.

9.

Oral multicomponent DNA vaccine delivered by attenuated Salmonella elicited immunoprotection against American trypanosomiasis.

Cazorla SI, Matos MN, Cerny N, Ramirez C, Alberti AS, Bivona AE, Morales C, Guzmán CA, Malchiodi EL.

J Infect Dis. 2015 Mar 1;211(5):698-707. doi: 10.1093/infdis/jiu480. Epub 2014 Aug 25.

PMID:
25160983

Supplemental Content

Loading ...
Support Center